MRONJ Risk in Individuals on Pharmacotherapy for Fracture Prevention

Join Drs. Laura Carbone and Pritee Shrestha as the present, "MRONJ Risk in Individuals on Pharmacotherapy for Fracture Prevention."

Learning Objectives:
1. Define medication-related osteonecrosis of the jaw (MRONJ) and discuss the challenges of identifying MRONJ using administrative claims data alone 
2. Describe the utility of an algorithm developed using  Natural Language Processing (NLP) Methodology to ascertain MRONJ 
3. Review the incidence of MRONJ among patients receiving bisphosphonates for fracture prevention, including relationships with duration of treatment with bisphosphonates. 
4. Identify patient- and treatment-related risk factors for MRONJ in patients receiving bisphosphonate therapy.